| scholarly article | Q13442814 |
| P50 | author | Mohammed Uddin | Q93050626 |
| P2093 | author name string | Syed S Islam | |
| Marc Woodbury-Smith | |||
| Rayhana Awwal | |||
| Bakhrom K Berdiev | |||
| Md Robed Amin | |||
| Mohammad Mizanur Rahman | |||
| Aaysha Siddiqua | |||
| Ahmed Sayeed | |||
| Bisan Samara | |||
| Hosneara Akter | |||
| K M Furkan Uddin | |||
| Md Abdul Baqui | |||
| Md Atikur Rahaman | |||
| Md Rashidul Hoq | |||
| Mohammed Basiruzzaman | |||
| Nasima Sultana | |||
| Nazrana Martuza | |||
| Nushrat Jahan Dity | |||
| P2860 | cites work | BRCA2 associates with acetyltransferase activity when bound to P/CAF | Q22008033 |
| Fast and accurate short read alignment with Burrows-Wheeler transform | Q24653853 | ||
| Meta-analysis of BRCA1 and BRCA2 penetrance | Q24654786 | ||
| How many more breast cancer predisposition genes are there? | Q24800566 | ||
| BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure | Q27639649 | ||
| Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach | Q27649882 | ||
| The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data | Q27860742 | ||
| DSS1 is required for the stability of BRCA2 | Q28115992 | ||
| Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2 | Q28212276 | ||
| Mutations in the p53 gene occur in diverse human tumour types | Q28249770 | ||
| RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2 | Q28257035 | ||
| A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase | Q29615980 | ||
| Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms | Q29618586 | ||
| BRCA2 is required for homology-directed repair of chromosomal breaks | Q29618799 | ||
| Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial | Q30080035 | ||
| The breast cancer information core: database design, structure, and scope | Q30482109 | ||
| Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families | Q33570260 | ||
| Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study | Q33609681 | ||
| Serum sonic hedgehog (SHH) and interleukin-(IL-6) as dual prognostic biomarkers in progressive metastatic breast cancer. | Q33686729 | ||
| Clinical implications of genomic profiles in metastatic breast cancer with a focus on TP53 and PIK3CA, the most frequently mutated genes | Q33709537 | ||
| p53 and human cancer: the first ten thousand mutations. | Q33767112 | ||
| Association between the BRCA2 rs144848 polymorphism and cancer susceptibility: a meta-analysis | Q33889402 | ||
| Landscape of somatic mutations in 560 breast cancer whole-genome sequences | Q34046731 | ||
| A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes | Q34385903 | ||
| Functional differences among BRCA1 missense mutations in the control of centrosome duplication | Q34461518 | ||
| Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology | Q34465792 | ||
| Cancer risks in BRCA2 mutation carriers | Q34504452 | ||
| Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium | Q34724404 | ||
| Cancer survival in five continents: a worldwide population-based study (CONCORD). | Q34798041 | ||
| Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes | Q35849056 | ||
| Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer | Q35957703 | ||
| BRCA1 and BRCA2 mutation testing in Cyprus; a population based study | Q36203178 | ||
| Prediction of breast cancer risk based on profiling with common genetic variants | Q36583004 | ||
| Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations | Q37597399 | ||
| ClinVar: public archive of relationships among sequence variation and human phenotype | Q37661886 | ||
| p53 in breast cancer subtypes and new insights into response to chemotherapy | Q38145813 | ||
| Depletion of DSS1 protein disables homologous recombinational repair in human cells | Q39659591 | ||
| The IARC TP53 database: new online mutation analysis and recommendations to users | Q43714274 | ||
| A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability | Q45181384 | ||
| Comprehensive prediction of mRNA splicing effects of BRCA1 and BRCA2 variants | Q46963880 | ||
| Targeting mutant p53 for efficient cancer therapy. | Q47291772 | ||
| Variants of unknown significance in BRCA testing: impact on risk perception, worry, prevention and counseling. | Q50760118 | ||
| BRCA2 variant aerodigestive cancer risk. | Q53546519 | ||
| Somatic mutations of ERBB2 kinase domain in gastric, colorectal, and breast carcinomas. | Q53606400 | ||
| Germline breast cancer susceptibility gene mutations and breast cancer outcomes. | Q54945937 | ||
| Breast cancer survival predicted by TP53 mutation status differs markedly depending on treatment | Q57053007 | ||
| p53 mutations in ovarian cancer: a late event? | Q57287785 | ||
| BRCA2 arg372hispolymorphism and epithelial ovarian cancer risk | Q57306056 | ||
| BRCA1Mutations in a Population-Based Sample of Young Women with Breast Cancer | Q57634603 | ||
| Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries | Q60142201 | ||
| Antibody-drug conjugate T-DM1 treatment for HER2+ breast cancer induces ROR1 and confers resistance through activation of Hippo transcriptional coactivator YAP1. | Q64886603 | ||
| Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer | Q70812480 | ||
| The BRCA2-Interacting Protein DSS1 Is Vital for DNA Repair, Recombination, and Genome Stability in Ustilago maydis | Q79212406 | ||
| Common variation in BRCA2 and breast cancer risk: a haplotype-based analysis in the Multiethnic Cohort | Q80467792 | ||
| The BRCA1 and BRCA2 Genes in Early-Onset Breast Cancer Patients | Q88450992 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 150 | |
| P577 | publication date | 2019-09-02 | |
| P1433 | published in | BMC Medical Genetics | Q15759918 |
| P1476 | title | Novel mutations in actionable breast cancer genes by targeted sequencing in an ethnically homogenous cohort | |
| P478 | volume | 20 |
Search more.